A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials
Author:
Affiliation:
1. Translational Medicine; Sanofi; Frankfurt Germany
2. Charité Research Organisation GmbH; Berlin Germany
3. R&D Clinical Sciences; Sanofi; Frankfurt Germany
4. R&D Diabetes Division; Sanofi; Frankfurt Germany
Funder
Sanofi
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13494/fullpdf
Reference42 articles.
1. World Health Organization http://www.who.int/mediacentre/factsheets/fs311/en/
2. Rate and risk predictors for development of self-reported type-2 diabetes mellitus over a 5-year period: the SHIELD study;Rodbard;Int J Clin Pract,2012
3. Prevalence and outcomes of comorbid metabolic and cardiovascular conditions in middle- and older-age adults;Oldridge;J Clin Epidemiol,2001
4. World Health Organization http://www.who.int/mediacentre/factsheets/fs312/en/
5. Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity;Burcelin;Obes Rev,2017
Cited by 142 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes;Expert Opinion on Drug Metabolism & Toxicology;2024-09-13
2. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17
3. The Inferential Binding Sites of GCGR for Small Molecules Using Protein Dynamic Conformations and Crystal Structures;International Journal of Molecular Sciences;2024-08-01
4. Transforming obesity: The advancement of multi-receptor drugs;Cell;2024-07
5. Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity;Diabetes, Obesity and Metabolism;2024-06-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3